Tramazoline turns asymptomatic into symptomatic hyper-CK-emia.
Finsterer
J
J
Fröhlinger
W
W
D000328:Adult; D015984:Causality; D052283:Creatine Kinase, MM Form / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D009120:Muscle Cramp / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000201:enzymology / Q000503:physiopathology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000201:enzymology / Q000503:physiopathology; D020127:Recovery of Function / Q000502:physiology; D013375:Substance Withdrawal Syndrome / Q000201:enzymology / Q000503:physiopathology*; D013566:Sympathomimetics / Q000009:adverse effects
D007093:Imidazoles; D013566:Sympathomimetics; D052283:Creatine Kinase, MM Form; C005370:tramazoline